Skip to content
EFXEquifax

What Is EFX Fair Value?

Equifax (EFX) fair value estimate using multiple valuation models, updated daily.

As of July 16, 2026, Equifax (EFX) has a composite fair value estimate of $158.08 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $171.61, suggesting the stock is fair value by 7.9%.

Data as of July 16, 2026 (today)

Composite Fair Value

Fair Value4 of 4 models

$158.08

vs. current price of $171.61(-7.9%)

Undervalued$158.08Overvalued
$171.61

How Is EFX Fair Value Calculated?

Four independent models estimate what EFX is worth. Each uses different inputs and assumptions. The composite blends them by weight.

EFX Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$225.37

+31.3%

Undervalued

Inputs used

FCF: 1BGrowth: 15.9%Discount: 10%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$64.01

-62.7%

Overvalued

Inputs used

Dividend: $2.24/yrReq. Return: 12%Growth: 8.0%

EFX Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$85.81

-50.0%

Overvalued

Inputs used

EPS: $8.60Book Value: $38.06

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$136.90

-20.2%

Overvalued

Inputs used

EPS: $8.60Growth: 15.9%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$225.37Undervalued

Current price $171.61 is 31.3% below this estimate

CheapFair ValueExpensive
15.9%
0.0%30.0%
10.1%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$1.19B$1.08B
Year 2$1.38B$1.14B
Year 3$1.60B$1.19B
Year 4$1.85B$1.26B
Year 5$2.14B$1.32B
Year 6$2.49B$1.39B
Year 7$2.88B$1.47B
Year 8$3.34B$1.54B
Year 9$3.87B$1.62B
Year 10$4.49B$1.71B
Terminal Value$60.29B$22.97B

What Are EFX's Key Financial Metrics?

Earnings & Growth

Current Price

$171.61

EPS (TTM)

$5.83

Forward P/E

16.7

Profit Margin

11.1%

Cash & Balance Sheet

Free Cash Flow

1B

EBITDA

1.9B

Book Value

$38.06

Total Debt

5.3B

What Do Analysts Say About EFX?

Low

$173.00

Average

$219.67

High

$265.00

Upside

+28.0%

Current $171.61Avg Target $219.67Buy21 analysts

EFX Fair Value FAQ

What is the fair value of EFX?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), EFX's estimated fair value is $158.08. The stock is currently trading at $171.61, which makes it fair value by our analysis.

How is EFX's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is EFX overvalued or undervalued?

Based on our analysis, EFX is fair value. The current price of $171.61 is 7.9% above our estimated fair value of $158.08.

What do Wall Street analysts say about EFX?

21 analysts cover Equifax with a consensus rating of "Buy." The average price target is $219.67, ranging from $173.00 to $265.00. This implies 28.0% upside from the current price.